• The Weight-Loss Shots Semaglutide and Tirzepatide: Controversy and Understanding their Use

  • May 30 2023
  • Length: 30 mins
  • Podcast

The Weight-Loss Shots Semaglutide and Tirzepatide: Controversy and Understanding their Use By cover art

The Weight-Loss Shots Semaglutide and Tirzepatide: Controversy and Understanding their Use

Listen for free

View show details

  • Summary

  • This presentation is on the medications semaglutide and tirzepatide , prescribed under brand names such as Ozempic, Wegovy and Monjaro, and others, some of which are in development. These drugs are GLP-1 agonist medications most commonly used for the treatment of type 2 diabetes, but more recently it’s been in the spotlight as a medication for weight loss, causing controversy, misunderstanding, questions and significant shortages of the medication.

    Dr. DeSarbo will briefly look at these medications from all perspectives including their use in diabetes, as a weight loss drug for the medical definition of obesity, and their potential impact and fallout with the eating disorder population.
    Show more Show less
activate_primeday_promo_in_buybox_DT
Show more Show less

What listeners say about The Weight-Loss Shots Semaglutide and Tirzepatide: Controversy and Understanding their Use

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available